Ukraine registers single-dose COVID-19 vaccine Janssen manufactured by Johnson&Johnson
Ukraine has registered a vaccine against coronavirus (COVID-19) Janssen manufactured by Johnson & Johnson.
According to the Center for Public Health and the Health Ministry, the vaccine was registered for emergency medical use on July 2.
At the same time, it is specified that one dose of Janssen vaccine is sufficient for complete immunization.
The vaccine is approved for emergency use by WHO. The United States, Great Britain, the European Union, Switzerland, Canada and other countries have also given permission to use it.
This is a vector vaccine developed by Janssen, owned by Johnson&Johnson. It requires a storage temperature from minus two to plus eight degrees Celsius.
Advertising
Advertising
MORE ABOUT
UNICEF delivers 136,000 doses of DPT vaccine to Ukraine as part of Ukraine's cooperation with Gavi
17:13, 13.08.2025
Sanofi plans to supply 50,000 doses of flu vaccine to private market in Ukraine this epidemic season
09:32, 30.09.2022
UNICEF provides Ukraine with 100,000 doses of Covid-19 Vaccine Janssen (Jcovden) under COVAX initiative
15:38, 25.08.2022
Health Ministry to begin delivering single-dose COVID-19 vaccine by Johnson & Johnson around Ukraine
13:48, 10.08.2022
Liashko: almost 31 mln doses of COVID-19 vaccine imported to Ukraine, another 2.5 mln doses of Pfizer vaccine expected this week
10:49, 09.11.2021
LATEST
Shmyhal: Govt proposes new contracts for Ukrainian Army with fixed terms of service
21:03, 05.12.2025
IAEA to assess more than 10 critical substations during Dec 1–12 visit to Ukraine – Grossi
20:51, 05.12.2025
Ukrainian Cultural Heritage Fund has already secured over EUR 4 mln in intl support – minister
20:34, 05.12.2025
Tenth Mountain Assault Brigade announces probable execution of captured Ukrainian soldier by Russians
20:07, 05.12.2025
Ukraine's state budget 2026 allocates UAH 298.8 bln for education, science